Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

DAXOR CORP

DXR · Nasdaq · CIK 0000027367 · Closed-End Funds · Medical Instruments & Supplies

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

4 Form 4 transaction lines observed in the same window
0 sales · 4 option, withholding, award, gift or other lines

Last qualifying purchase2026-04-08 · Feldschuh Michael Richard · $9.1K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Michel Robert JChief Financial Officer
○
Feldschuh Michael RichardChief Executive Officer
○
Feldschuh Jonathan AdamChief Scientific Officer
○
Jefferies JohnChief Medical Officer
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

40.8 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 40.9
  2. 40.8
  3. 40.8
  4. 40.8
  5. 40.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

7Purchases
0Sales
4Other Form 4 lines
10SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER4 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
6,959
Previous report
2,331
Avg daily volume
38,746
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-04-08Feldschuh Michael RichardPurchase (P)Daxor Common Stock1,000USD 9.07USD 9,070SEC filing ↗
2026-03-31Michel Robert JPurchase (P)Daxor Common Stock1,000USD 9.90USD 9,900SEC filing ↗
2026-03-20Jefferies JohnPurchase (P)Daxor Common Stock5,941USD 0.00USD 0SEC filing ↗
2025-12-09Michel Robert JPurchase (P)Daxor Common Stock3,000USD 0.00USD 0SEC filing ↗
2025-12-09Feldschuh Jonathan AdamPurchase (P)Daxor Common Stock18,000USD 0.00USD 0SEC filing ↗
2025-11-12Jefferies JohnPurchase (P)Daxor Common Stock2,344USD 0.00USD 0SEC filing ↗
2025-04-04Feldschuh Michael RichardPurchase (P)Daxor Common Stock2,063USD 7.89USD 16,277SEC filing ↗
2025-03-10Michel Robert JPurchase (P)Daxor Common Stock1,000USD 8.00USD 8,000SEC filing ↗
2025-03-10Feldschuh Michael RichardPurchase (P)Daxor Common Stock3,360USD 7.68USD 25,805SEC filing ↗
2024-12-06Feldschuh Michael RichardPurchase (P)Daxor Common Stock45,000USD 0.00USD 0SEC filing ↗
2024-12-06Feldschuh Jonathan AdamPurchase (P)Daxor Common Stock32,000USD 0.00USD 0SEC filing ↗
2024-03-27Michel Robert JPurchase (P)Daxor Common Stock750USD 8.70USD 6,525SEC filing ↗
2024-03-26Feldschuh Michael RichardPurchase (P)Daxor Common Stock1,000USD 8.13USD 8,130SEC filing ↗
2024-03-19Feldschuh Michael RichardPurchase (P)Daxor Common Stock647USD 8.15USD 5,273SEC filing ↗
2024-03-10Feldschuh Michael RichardPurchase (P)Daxor Common Stock1,492USD 7.72USD 11,518SEC filing ↗

Form 4 evidence

11 transaction lines in the latest 365-day window; 41 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-28Jefferies JohnAward / grant (A)Daxor Common Stock2,451USD 0.00USD 0SEC filing ↗
2026-06-23Michel Robert JAward / grant (A)Daxor Common Stock12,000USD 0.00USD 0SEC filing ↗
2026-06-23Feldschuh Michael RichardAward / grant (A)Daxor Common Stock30,000USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (10 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-28Jefferies JohnAward / grant (A)Daxor Common Stock2,451USD 0.00USD 0SEC filing ↗
2026-06-23Michel Robert JAward / grant (A)Daxor Common Stock12,000USD 0.00USD 0SEC filing ↗
2026-06-23Feldschuh Michael RichardAward / grant (A)Daxor Common Stock30,000USD 0.00USD 0SEC filing ↗
2026-06-23Feldschuh Jonathan AdamAward / grant (A)Daxor Common Stock25,000USD 0.00USD 0SEC filing ↗
2026-04-08Feldschuh Michael RichardPurchase (P)Daxor Common Stock1,000USD 9.07USD 9,070SEC filing ↗
2026-03-31Michel Robert JPurchase (P)Daxor Common Stock1,000USD 9.90USD 9,900SEC filing ↗
2026-03-20Jefferies JohnPurchase (P)Daxor Common Stock5,941USD 0.00USD 0SEC filing ↗
2025-12-09Michel Robert JPurchase (P)Daxor Common Stock3,000USD 0.00USD 0SEC filing ↗
2025-12-09Feldschuh Jonathan AdamPurchase (P)Daxor Common Stock18,000USD 0.00USD 0SEC filing ↗
2025-11-12Jefferies JohnPurchase (P)Daxor Common Stock2,344USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerDXR
CIK0000027367
SectorClosed-End Funds
IndustryMedical Instruments & Supplies Yahoo Finance
SEC SICInvestment company (SEC forms N-2, N-2/A, N-CEN)
ExchangeNasdaq

Data coverage

Local Form 4 history41 transaction lines from 2020-07-22 to 2026-08-28
31 P purchase lines · 0 S sale lines · 10 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.